molsidomine has been researched along with Respiratory Distress Syndrome in 3 studies
Molsidomine: A morpholinyl sydnone imine ethyl ester, having a nitrogen in place of the keto oxygen. It acts as NITRIC OXIDE DONORS and is a vasodilator that has been used in ANGINA PECTORIS.
molsidomine : A member of the class of oxadiazoles that is 1,2,3-oxadiazole substituted by morpholin-4-yl and (ethoxycarbonyl)azanidyl groups at positions 3 and 5, respectively. It is used as a vasodilator drug for the treatment of myocardial ischemic syndrome and congestive heart failure.
Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muzaffar, S | 1 |
| Shukla, N | 1 |
| Angelini, G | 1 |
| Jeremy, JY | 1 |
| Zhu, S | 1 |
| Basiouny, KF | 1 |
| Crow, JP | 1 |
| Matalon, S | 1 |
| Jean, D | 1 |
| Maître, B | 1 |
| Tankovic, J | 1 |
| Meignan, M | 1 |
| Adnot, S | 1 |
| Brun-Buisson, C | 1 |
| Harf, A | 1 |
| Delclaux, C | 1 |
3 other studies available for molsidomine and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Nitroaspirins and morpholinosydnonimine but not aspirin inhibit the formation of superoxide and the expression of gp91phox induced by endotoxin and cytokines in pig pulmonary artery vascular smooth muscle cells and endothelial cells.
Topics: Acetophenones; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Drug Evaluation, Preclinic | 2004 |
Carbon dioxide enhances nitration of surfactant protein A by activated alveolar macrophages.
Topics: Carbon Dioxide; Cells, Cultured; Enzyme Activation; Epithelial Cells; Humans; Hypercapnia; Lipid Met | 2000 |
Beneficial effects of nitric oxide inhalation on pulmonary bacterial clearance.
Topics: Administration, Inhalation; Animals; Blood Bactericidal Activity; Bronchoalveolar Lavage Fluid; Colo | 2002 |